🔗 Permalink

Inventor profile of:

Rob N. De Jong

City:

Utrecht

Country:

Netherlands

Published Applications:

Last publication date:

2025-11-06

Top Assignees for applications by Rob N. De Jong

The entities that hold a legal rights for patent applications filed by inventor De Jong Rob N.:

GENMAB A/S 5 Copenhagen V, Denmark
GENMAB A/S 2 Copenhagen, Denmark
GENMAB B.V. 2 Utrecht, Netherlands
GENMAB A/S 1 Valby, Denmark

Recent patent applications by De Jong Rob N.

Rob N. De Jong from Utrecht, NL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-06

US20250340669A1

Chemistry; metallurgy

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

#2 | 2025-10-23

US20250325643A1

Human necessities

BINDING AGENTS CAPABLE OF BINDING TO CD27 IN COMBINATION THERAPY

#3 | 2025-09-18

US20250289900A1

Chemistry; metallurgy

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

#4 | 2025-09-18

US20250289899A1

Chemistry; metallurgy

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

#5 | 2025-07-10

US20250223374A1

Chemistry; metallurgy

ANTIBODY VARIANTS AND USES THEREOF

#6 | 2025-05-08

US20250145720A1

Chemistry; metallurgy

HUMAN IGG1 FC REGION VARIANTS AND USES THEREOF

#7 | 2025-02-06

US20250043018A1

Chemistry; metallurgy

ANTIBODY VARIANTS AND USES THEREOF

#8 | 2024-03-21

US20240091352A1

Human necessities

ANTIBODIES BINDING AXL

#9 | 2023-12-28

US20230416403A1

Chemistry; metallurgy

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

#10 | 2023-07-06

US20230212301A1

Chemistry; metallurgy

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

#11 | 2023-04-06

US20230109496A1

Chemistry; metallurgy

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

#12 | 2023-03-23

US20230089196A1

Physics

METHODS FOR THE QUANTIFICATION OF GLYCOPROTEINS

#13 | 2021-07-29

US20210230301A1

Chemistry; metallurgy

DIMERIC PROTEIN WITH TRIPLE MUTATIONS

#14 | 2021-06-10

US20210171657A1

Chemistry; metallurgy

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

#15 | 2021-06-03

US20210163619A1

Chemistry; metallurgy

Antibody variants and uses thereof

#16 | 2020-06-04

US20200171152A1

Human necessities

ANTIBODIES BINDING AXL

#17 | 2019-09-12

US20190275149A1

Human necessities

Antibodies binding AXL

#18 | 2019-06-06

US20190169311A1

Chemistry; metallurgy

Human Antibodies Against Tissue Factor and Methods of Use Thereof

#19 | 2019-05-30

US20190160170A1

Human necessities

Antibodies binding AXL

#20 | 2018-08-02

US20180214549A1

Human necessities

Antibodies binding AXL

#21 | 2018-02-15

US20180044431A1

Chemistry; metallurgy

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

#22 | 2017-06-08

US20170157250A1

Human necessities

Antibodies binding AXL

#23 | 2016-02-25

US20160053020A1

Chemistry; metallurgy

Human antibodies against tissue factor and methods of use thereof

#24 | 2015-12-10

US20150353636A1

Chemistry; metallurgy

HUMAN IGG1 FC REGION VARIANTS AND USES THEREOF

#25 | 2015-06-25

US20150175707A1

Chemistry; metallurgy

Dimeric protein with triple mutations

#26 | 2011-12-08

US20110300156A1

Chemistry; metallurgy

Human antibodies against tissue factor and methods of use thereof

InventorID:

1204357 ⎘